Abstract
Background
The aim of this study was to estimate the impact of respiratory and electrocardiogram (ECG)-gated FDG positron emission tomography (PET)/computed tomography (CT) on the diagnosis of cardiac sarcoidosis (CS).
Methods and Results
Imaging from thirty-one patients was acquired on a PET/CT scanner equipped with a respiratory- and ECG-gating system. Non-gated PET images and three kinds of gated PET/CT images were created from identical list-mode clinical PET data: respiratory-gated PET during expiration (EX), ECG-gated PET at end diastole (ED), and ECG-gated PET at end systole (ES). The maximum standardized uptake value (SUVmax) and cardiac metabolic volume (CMV) were measured, and the locations of FDG accumulation were analyzed using a polar map. The mean SUVmax of the subjects was significantly higher after application of either respiratory-gated or ECG-gated reconstruction. Conversely, the mean CMV was significantly lower following the application of respiratory-gated or ECG-gated reconstruction. The segment showing maximum accumulation was shifted to the adjacent segment in 25.8%, 38.7%, and 41.9% of cases in EX, ED, and ES images, respectively.
Conclusion
In FDG PET/CT scanning for the diagnosis of CS, gated scanning is likely to increase quantitative accuracy, but the effect depends on the location and synchronization method.
Abbreviations
- CMV:
-
Cardiac metabolic volume
- CS:
-
Cardiac sarcoidosis
- FDG:
-
Fluorine-18-fluorodeoxyglucose
- PET:
-
Positron emission tomography
- SUVmax:
-
Maximum standardized uptake value
References
Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224‐34.
Gilotra N, Okada D, Sharma A, Chrispin J. Management of Cardiac Sarcoidosis in 2020. Arrhythm Electrophysiol Rev 2020;9:182‐8.
Rathi VK, Biederman RW. Imaging of ventricular function by cardiovascular magnetic resonance. Curr Cardiol Rep 2004;6:55‐61.
Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T. Diagnostic utility of fusion (18)F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol 2022;29:753‐64.
Livieratos L, Rajappan K, Stegger L, Schafers K, Bailey DL, Camici PG. Respiratory gating of cardiac PET data in list-mode acquisition. Eur J Nucl Med Mol Imaging 2006;33:584‐8.
Okuda K, Nakajima K. Has the era of dual-gated myocardial perfusion SPECT and PET arrived? J Nucl Cardiol 2020;27:648‐50.
Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014;28:393‐403.
Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121‐51.
Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis. Digest Version Circ J 2019;83:2329‐88.
Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801‐10.
Watanabe S, Hanaoka K, Shibata Y, Kaida H, Ishii K. Usefulness of respiratory-gated 18F-FDG PET/CT scan protocol in patients having positive myocardial 18F-FDG uptake. Nucl Med Commun 2019;40:235‐41.
Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A, et al. Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake. J Nucl Cardiol 2019;26:909‐18.
Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138‐47.
Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253‐8.
Miller RJH, Cadet S, Pournazari P, Pope A, Kransdorf E, Hamilton MA, et al. Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis. J Nucl Cardiol 2022;29:86‐96.
Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010;3:1219‐28.
Manabe O, Ohira H, Hirata K, Hayashi S, Naya M, Tsujino I, et al. Use of (18)F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2019;46:1240‐7.
Keall PJ, Kini VR, Vedam SS, Mohan R. Motion adaptive X-ray therapy: A feasibility study. Phys Med Biol 2001;46:1‐10.
Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, et al. CT vs 68Ge attenuation correction in a combined PET/CT system: Evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002;29:346‐50.
Kovalski G, Keidar Z, Frenkel A, Sachs J, Attia S, Azhari H. Dual, “motion-frozen heart” combining respiration and contraction compensation in clinical myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:396‐404.
Acknowledgements
We thank Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.
Disclosures
The authors Kohei Hanaoka PhD, Shota Watanabe PhD, Daisuke Morimoto-Ishikawa MS, Hayato Kaida MD, PhD, Takahiro Yamada PhD, Masakazu Yasuda MD, PhD, Yoshitaka Iwanaga MD, PhD, Gaku Nakazawa MD, PhD, and Kazunari Ishii MD, PhD declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hanaoka, K., Watanabe, S., Morimoto-Ishikawa, D. et al. Impact of respiratory gating and ECG gating on 18F-FDG PET/CT for cardiac sarcoidosis. J. Nucl. Cardiol. 30, 1879–1885 (2023). https://doi.org/10.1007/s12350-023-03236-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-023-03236-0